Skip to main content
. 2019 Apr 18;49(2):644–652. doi: 10.3906/sag-1812-125

Table 2.

Demographic characterictics, hemoglobin levels, clinical diagnoses, SIR values, and biopsy results of group 2.

Case Sex Age Weight Hb level (mg/dl) History of hematological malignancy SIR **BM biopsy results
1 Female 23 54 13 ***( - ) 0.58 No BM biopsy Stable at follow-up
2 Female 41 69 12 ***( - ) 0.8 No BM biopsy Stable at follow-up
3 Female 27 70 11 ***( - ) 0.67 No BM biopsy Stable at follow-up
4 Male 46 85 10 ***( - ) 0.5 Hypercellular BM
5 Female 37 65 13 ***( - ) 0.81 Normocellular BM
6 Male 61 70 10 ***( - ) 0.73 Hypercellular BM
7 Female 25 90 14 ***( - ) 0.59 No BM biopsy Stable at follow-up
8 Male 61 75 10 ***( - ) 0.65 No BM biopsy Stable at follow-up
9 Male 35 60 9 ***( - ) 1.22 Hypercellular BM
10 Female 39 88 7 *(+) 0.63 Hypercellular BM
11 Male 34 70 7 *(+) 1.3 Hypercellular BM
12 Male 46 74 9 *(+) 1.16 Hypercellular BM
13 Female 54 78 13 ***( - ) 0.69 No BM biopsy Stable at follow-up
14 Female 33 72 13 ***( - ) 0.27 No BM biopsy Stable at follow-up
15 Male 41 89 14 ***( - ) 0.21 No BM biopsy Stable at follow-up
16 Female 51 60 11 ***( - ) 0.35 No BM biopsy Stable at follow-up

Hb: Hemoglobin, SIR: Signal intensity ratio, BM: Bone marrow *( + ): Patients who had history of hematological malignancy. **: BM results at at the time of MRI imaging. ***( - ): Patient who had no history of hematological malignancy.